Abnormal 0 8 0 8 B-chronic_disease
liver 9 14 9 14 I-chronic_disease
function 15 23 15 23 I-chronic_disease
as 24 26 24 26 O
defined 27 34 27 34 O
by 35 37 35 37 O
aspartate 38 47 38 47 B-clinical_variable
aminotransferase 48 64 48 64 I-clinical_variable
( 65 66 65 66 I-clinical_variable
AST 66 69 66 69 I-clinical_variable
) 69 70 69 70 I-clinical_variable
, 70 71 70 71 O
alanine 72 79 72 79 B-clinical_variable
aminotransferase 80 96 80 96 I-clinical_variable
( 97 98 97 98 I-clinical_variable
ALT 98 101 98 101 I-clinical_variable
) 101 102 101 102 I-clinical_variable
or 103 105 103 105 O
bilirubin 106 115 106 115 B-clinical_variable
> 116 117 116 117 O
upper 118 123 118 123 O
limit 124 129 124 129 O
of 130 132 130 132 O
the 133 136 133 136 O
normal 137 143 137 143 O
range 144 149 144 149 O

Body 0 4 150 154 B-bmi
mass 5 9 155 159 I-bmi
index 10 15 160 165 I-bmi
( 16 17 166 167 I-bmi
BMI 17 20 167 170 I-bmi
) 20 21 170 171 I-bmi
â‰¥18 22 25 172 175 O
to 26 28 176 178 O
< 29 30 179 180 O
30 30 32 180 182 B-upper_bound
kg 33 35 183 185 I-upper_bound
/ 35 36 185 186 I-upper_bound
m2 36 38 186 188 I-upper_bound

Concomitant 0 11 189 200 O
use 12 15 201 204 O
of 16 18 205 207 O
known 19 24 208 213 O
strong 25 31 214 220 O
or 32 34 221 223 O
moderate 35 43 224 232 O
inhibitors 44 54 233 243 O
or 55 57 244 246 O
inducers 58 66 247 255 O
of 67 69 256 258 O
CYP1A2 70 76 259 265 B-treatment
, 76 77 265 266 O
CYP2B6 78 84 267 273 B-treatment
, 84 85 273 274 O
and 86 89 275 278 O
CYP3A4 90 96 279 285 B-treatment
within 97 103 286 292 O
14 104 106 293 295 B-upper_bound
days 107 111 296 300 I-upper_bound
or 112 114 301 303 O
5 115 116 304 305 O
half 117 121 306 310 O
- 121 122 310 311 O
lives 122 127 311 316 O
( 128 129 317 318 O
whichever 129 138 318 327 O
is 139 141 328 330 O
longer 142 148 331 337 O
) 148 149 337 338 O
prior 150 155 339 344 O
to 156 158 345 347 O
Day 159 162 348 351 O
1 163 164 352 353 O
and 165 168 354 357 O
through 169 176 358 365 O
the 177 180 366 369 O
last 181 185 370 374 O
PK 186 188 375 377 O
sampling 189 197 378 386 O
point 198 203 387 392 O
on 204 206 393 395 O
Day 207 210 396 399 O
20 211 213 400 402 O

Currently 0 9 403 412 O
taking 10 16 413 419 O
or 17 19 420 422 O
has 20 23 423 426 O
taken 24 29 427 432 O
a 30 31 433 434 O
CFTR 32 36 435 439 B-treatment
modulator 37 46 440 449 I-treatment
within 47 53 450 456 O
30 54 56 457 459 B-upper_bound
days 57 61 460 464 I-upper_bound
prior 62 67 465 470 I-upper_bound
to 68 70 471 473 O
initial 71 78 474 481 O
dose 79 83 482 486 O
of 84 86 487 489 O
study 87 92 490 495 O
drugs 93 98 496 501 O

Forced 0 6 502 508 B-clinical_variable
expiratory 7 17 509 519 I-clinical_variable
volume 18 24 520 526 I-clinical_variable
in 25 27 527 529 I-clinical_variable
1 28 29 530 531 I-clinical_variable
second 30 36 532 538 I-clinical_variable
( 37 38 539 540 I-clinical_variable
FEV1 38 42 540 544 I-clinical_variable
) 42 43 544 545 I-clinical_variable
40 44 46 546 548 B-lower_bound
- 46 47 548 549 O
90 47 49 549 551 B-upper_bound
% 49 50 551 552 I-upper_bound
predicted 51 60 553 562 O

Non 0 3 563 566 O
- 3 4 566 567 O
smoker 4 10 567 573 O
and 11 14 574 577 O
non 15 18 578 581 O
- 18 19 581 582 O
tobacco 19 26 582 589 O
user 27 31 590 594 O
for 32 35 595 598 O
a 36 37 599 600 O
minimum 38 45 601 608 O
of 46 48 609 611 O
30 49 51 612 614 B-lower_bound
days 52 56 615 619 I-lower_bound
prior 57 62 620 625 I-lower_bound
to 63 65 626 628 O
screening 66 75 629 638 O

Participation 0 13 639 652 O
in 14 16 653 655 O
another 17 24 656 663 B-treatment
clinical 25 33 664 672 I-treatment
trial 34 39 673 678 I-treatment
or 40 42 679 681 O
treatment 43 52 682 691 B-treatment
with 53 57 692 696 I-treatment
an 58 60 697 699 I-treatment
investigational 61 76 700 715 I-treatment
agent 77 82 716 721 I-treatment
within 83 89 722 728 O
28 90 92 729 731 B-upper_bound
days 93 97 732 736 I-upper_bound
or 98 100 737 739 O
5 101 102 740 741 O
half 103 107 742 746 O
- 107 108 746 747 O
lives 108 113 747 752 O
, 113 114 752 753 O
whichever 115 124 754 763 O
is 125 127 764 766 O
longer 128 134 767 773 O
, 134 135 773 774 O
prior 136 141 775 780 O
to 142 144 781 783 O
Study 145 150 784 789 O
Day 151 154 790 793 O
1 155 156 794 795 O

Positive 0 8 796 804 O
blood 9 14 805 810 O
screen 15 21 811 817 O
for 22 25 818 821 O
human 26 31 822 827 B-chronic_disease
immunodeficiency 32 48 828 844 I-chronic_disease
virus 49 54 845 850 I-chronic_disease
( 55 56 851 852 I-chronic_disease
HIV 56 59 852 855 I-chronic_disease
) 59 60 855 856 I-chronic_disease
, 60 61 856 857 O
hepatitis 62 71 858 867 B-chronic_disease
B 72 73 868 869 I-chronic_disease
surface 74 81 870 877 I-chronic_disease
antigen 82 89 878 885 I-chronic_disease
( 90 91 886 887 I-chronic_disease
HBsAg 91 96 887 892 I-chronic_disease
) 96 97 892 893 I-chronic_disease
, 97 98 893 894 O
or 99 101 895 897 O
hepatitis 102 111 898 907 B-chronic_disease
C 112 113 908 909 I-chronic_disease
virus 114 119 910 915 I-chronic_disease
antibody 120 128 916 924 I-chronic_disease
( 129 130 925 926 I-chronic_disease
HCVAb 130 135 926 931 I-chronic_disease
) 135 136 931 932 I-chronic_disease

Pregnant 0 8 933 941 B-pregnancy

Stable 0 6 942 948 O
on 7 9 949 951 O
ivacaftor 10 19 952 961 B-treatment
/ 19 20 961 962 I-treatment
lumacaftor 20 30 962 972 I-treatment
dosing 31 37 973 979 O
for 38 41 980 983 O
both 42 46 984 988 O
label 47 52 989 994 O
indication 53 63 995 1005 O
and 64 67 1006 1009 O
per 68 71 1010 1013 O
label 72 77 1014 1019 O
dosing 78 84 1020 1026 O
for 85 88 1027 1030 O
a 89 90 1031 1032 O
minimum 91 98 1033 1040 O
of 99 101 1041 1043 O
3 102 103 1044 1045 B-lower_bound
months 104 110 1046 1052 I-lower_bound
at 111 113 1053 1055 O
the 114 117 1056 1059 O
time 118 122 1060 1064 O
of 123 125 1065 1067 O
dosing 126 132 1068 1074 O

Stable 0 6 1075 1081 O
on 7 9 1082 1084 O
tezacaftor 10 20 1085 1095 B-treatment
/ 20 21 1095 1096 O
ivacaftor 21 30 1096 1105 B-treatment
dosing 31 37 1106 1112 O
for 38 41 1113 1116 O
both 42 46 1117 1121 O
label 47 52 1122 1127 O
indication 53 63 1128 1138 O
and 64 67 1139 1142 O
per 68 71 1143 1146 O
label 72 77 1147 1152 O
dosing 78 84 1153 1159 O
for 85 88 1160 1163 O
a 89 90 1164 1165 O
minimum 91 98 1166 1173 O
of 99 101 1174 1176 O
1 102 103 1177 1178 B-upper_bound
month 104 109 1179 1184 I-upper_bound
at 110 112 1185 1187 O
the 113 116 1188 1191 O
time 117 121 1192 1196 O
dosing 122 128 1197 1203 O

Use 0 3 1204 1207 O
of 4 6 1208 1210 O
grapefruit- 7 18 1211 1222 B-treatment
or 19 21 1223 1225 O
Seville 22 29 1226 1233 B-treatment
orange 30 36 1234 1240 I-treatment
- 36 37 1240 1241 I-treatment
containing 37 47 1241 1251 I-treatment
products 48 56 1252 1260 I-treatment
within 57 63 1261 1267 O
48 64 66 1268 1270 B-upper_bound
hours 67 72 1271 1276 I-upper_bound
prior 73 78 1277 1282 O
to 79 81 1283 1285 O
Day 82 85 1286 1289 O
1 86 87 1290 1291 O
and 88 91 1292 1295 O
through 92 99 1296 1303 O
the 100 103 1304 1307 O
last 104 108 1308 1312 O
PK 109 111 1313 1315 O
sampling 112 120 1316 1324 O
point 121 126 1325 1330 O
on 127 129 1331 1333 O
Day 130 133 1334 1337 O
20 134 136 1338 1340 O

age 0 3 1341 1344 B-age
18 4 6 1345 1347 B-lower_bound
to 7 9 1348 1350 O
55 10 12 1351 1353 B-upper_bound
years 13 18 1354 1359 I-upper_bound
old 19 22 1360 1363 O

alcohol 0 7 1364 1371 O
or 8 10 1372 1374 O
drug 11 15 1375 1379 O
abuse 16 21 1380 1385 O
or 22 24 1386 1388 O
dependence 25 35 1389 1399 O
within 36 42 1400 1406 O
12 43 45 1407 1409 B-upper_bound
months 46 52 1410 1416 I-upper_bound
of 53 55 1417 1419 O
screening 56 65 1420 1429 O
as 66 68 1430 1432 O
determined 69 79 1433 1443 O
by 80 82 1444 1446 O
the 83 86 1447 1450 O
investigator 87 99 1451 1463 O

cancer 0 6 1464 1470 B-cancer
within 7 13 1471 1477 O
the 14 17 1478 1481 O
past 18 22 1482 1486 B-upper_bound
5 23 24 1487 1488 I-upper_bound
years 25 30 1489 1494 I-upper_bound
( 31 32 1495 1496 O
excluding 32 41 1496 1505 O
cervical 42 50 1506 1514 B-cancer
cancer 51 57 1515 1521 I-cancer
in 58 60 1522 1524 I-cancer
situ 61 65 1525 1529 I-cancer
with 66 70 1530 1534 O
curative 71 79 1535 1543 B-treatment
therapy 80 87 1544 1551 I-treatment
for 88 91 1552 1555 O
at 92 94 1556 1558 O
least 95 100 1559 1564 O
one 101 104 1565 1568 B-lower_bound
year 105 109 1569 1573 I-lower_bound
prior 110 115 1574 1579 I-lower_bound
to 116 118 1580 1582 O
screening 119 128 1583 1592 O
and 129 132 1593 1596 O
non 133 136 1597 1600 B-cancer
- 136 137 1600 1601 I-cancer
melanoma 137 145 1601 1609 I-cancer
skin 146 150 1610 1614 I-cancer
cancer 151 157 1615 1621 I-cancer
) 157 158 1621 1622 O

diagnosis 0 9 1623 1632 O
of 10 12 1633 1635 O
CF 13 15 1636 1638 B-chronic_disease
with 16 20 1639 1643 O
the 21 24 1644 1647 O
F508del 25 32 1648 1655 B-treatment
/ 32 33 1655 1656 O
F508del 33 40 1656 1663 B-treatment
genotype 41 49 1664 1672 I-treatment
on 50 52 1673 1675 O
record 53 59 1676 1682 O
, 59 60 1682 1683 O
along 61 66 1684 1689 O
with 67 71 1690 1694 O
clinical 72 80 1695 1703 O
findings 81 89 1704 1712 O
consistent 90 100 1713 1723 O
with 101 105 1724 1728 O
CF 106 108 1729 1731 O
such 109 113 1732 1736 O
as 114 116 1737 1739 O
chronic 117 124 1740 1747 O
sinopulmonary 125 138 1748 1761 B-chronic_disease
disease 139 146 1762 1769 I-chronic_disease
or 147 149 1770 1772 O
gastrointestinal 150 166 1773 1789 B-chronic_disease
/ 166 167 1789 1790 O
nutritional 167 178 1790 1801 B-chronic_disease
abnormalities 179 192 1802 1815 I-chronic_disease

donated 0 7 1816 1823 O
blood 8 13 1824 1829 O
within 14 20 1830 1836 O
3 21 22 1837 1838 B-upper_bound
months 23 29 1839 1845 I-upper_bound
of 30 32 1846 1848 O
screening 33 42 1849 1858 O
or 43 45 1859 1861 O
plans 46 51 1862 1867 O
to 52 54 1868 1870 O
donate 55 61 1871 1877 O
blood 62 67 1878 1883 O
within 68 74 1884 1890 O
3 75 76 1891 1892 O
months 77 83 1893 1899 O
of 84 86 1900 1902 O
study 87 92 1903 1908 O
completion 93 103 1909 1919 O

nursing 0 7 1920 1927 O
women 8 13 1928 1933 B-gender

organ 0 5 1934 1939 B-treatment
transplantation 6 21 1940 1955 I-treatment

